Evidence map›Paper›PMID 38298116›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Fenofibrate Recognition and G

Tianxin Wang, Wenqin Tang, Ziyi Zhao, Ran Zhao, Zhenyu Lv, Xuzhen Guo, Quanchang Gu, Boxiang Liu, Haoyu Lv, Jiayan Chen and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Fenofibrate Recognition and GAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Tianxin WangCAS Key Laboratory of Quantitative Engineering Biology, Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Wenqin TangInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.
Ziyi ZhaoInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.
Ran ZhaoInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.
Zhenyu LvInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.
Xuzhen GuoCAS Key Laboratory of Quantitative Engineering Biology, Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
Quanchang GuInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.
Boxiang LiuiHuman Institute, ShanghaiTech University, 393 Middle Huaxia Road, Pudong, Shanghai, 201210, China.
Haoyu LviHuman Institute, ShanghaiTech University, 393 Middle Huaxia Road, Pudong, Shanghai, 201210, China.
Jiayan CheniHuman Institute, ShanghaiTech University, 393 Middle Huaxia Road, Pudong, Shanghai, 201210, China.
Kaiquan ZhangInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.
Fahui LiInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.ORCID 0000-0002-5977-2449
Jiangyun WangInstitute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Chaoyang District, Beijing, 100101, China.ORCID 0000-0002-5974-1562
Chinese Academy of Sciences · CNShanghaiTech University · CN

Funding

National Key Research and Development Program of China 2019YFA0904002National Key Research and Development Program of China 2019YFA0904100National Key Research and Development Program of China 2019YFA0904200National Key Research and Development Program of China 2020YFA0907701National Key Research and Development Program of China 2020YFA0908503National Key Research and Development Program of China 2021YFA0910202National Key Research and Development Program of China 2021YFA0910802National Key Research and Development Program of China 2022YFA1304701National Natural Science Foundation of China 21837005National Natural Science Foundation of China 22121003National Natural Science Foundation of China 22193023National Natural Science Foundation of China 31971200National Natural Science Foundation of China 32027901National Natural Science Foundation of China 91953202the CAS Project for Young Scientists in Basic Research YSBR-015the CAS Project for Young Scientists in Basic Research YSBR-072-6the Strategic Priority Research Program of Chinese Academy of Sciences XDB37040203
6 · The paper itself

Abstract

The G-protein-coupled human cannabinoid receptor 1 (CB1) is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders. The structures of CB1-G

Indexed as

CannabinoidsFenofibrateCryoelectron MicroscopyGTP-Binding ProteinsHumansReceptor, Cannabinoid, CB1CannabinoidsFenofibrateGTP-Binding ProteinsReceptor, Cannabinoid, CB1cryo‐electron microscopyfenofibrateGq couplinghuman cannabinoid receptor 1ligand recognition

Identifiers

PMID38298116
PMCPMC11005724
OpenAlexW4391442490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.